ETF Holdings Breakdown of CRL

Stock NameCreightons Plc
TickerCRL(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB0002341666
LEI213800WROWAJUBGSAJ57

News associated with CRL

Charles River Laboratories International (NYSE:CRL) Shares Gap Up After Earnings Beat
Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $115.41, but opened at $141.03. Charles River Laboratories International shares last traded at $134.46, with a volume of 1,274,674 shares […] - 2025-05-08 06:12:48
Insider Buying: Creightons Plc (LON:CRL) Insider Purchases 15,000 Shares of Stock
Creightons Plc (LON:CRL – Get Free Report) insider Jemima Bird purchased 15,000 shares of the stock in a transaction dated Friday, May 2nd. The shares were acquired at an average price of GBX 34 ($0.45) per share, with a total value of £5,100 ($6,780.11). Jemima Bird also recently made the following trade(s): On Monday, March […] - 2025-05-08 05:19:10
S&P 500 Movers: MRNA, CRL
In early trading on Wednesday, shares of Charles River Laboratories International topped the list of the day's best performing components of the S&P 500 index, trading up 19.9%. Year to date, Charles River Laboratories International has lost about 25.1% of its value. And t - 2025-05-07 14:19:08
Mariner LLC Sells 427 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Mariner LLC lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 19,648 shares of the medical research company’s stock after selling 427 shares during the period. Mariner LLC’s holdings in Charles River […] - 2025-04-22 08:48:52
Federated Hermes Inc. Sells 42,039 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Federated Hermes Inc. lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 94.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,397 shares of the medical research company’s stock after selling 42,039 shares during the period. Federated Hermes Inc.’s holdings […] - 2025-04-18 07:57:07
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Russell Investments Group Ltd.
Russell Investments Group Ltd. trimmed its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 29.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 30,445 shares of the medical research company’s stock after selling […] - 2025-04-15 08:20:53
Charles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Lowered by Orion Portfolio Solutions LLC
Orion Portfolio Solutions LLC trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 57.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,390 shares of the medical research company’s stock after selling 1,847 shares during the period. […] - 2025-04-10 08:44:52
JPMorgan Chase & Co. Has $85.32 Million Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
JPMorgan Chase & Co. reduced its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 462,170 shares of the medical research company’s stock after selling 20,575 shares during […] - 2025-04-04 08:23:08
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Corebridge Financial Inc.
Corebridge Financial Inc. lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,108 shares of the medical research company’s stock after selling 706 shares during the quarter. Corebridge Financial Inc.’s […] - 2025-04-02 08:27:11
Jemima Bird Buys 35,211 Shares of Creightons Plc (LON:CRL) Stock
Creightons Plc (LON:CRL – Get Free Report) insider Jemima Bird acquired 35,211 shares of Creightons stock in a transaction dated Monday, March 31st. The stock was bought at an average price of GBX 28 ($0.36) per share, with a total value of £9,859.08 ($12,746.06). Creightons Price Performance LON CRL opened at GBX 28.56 ($0.37) on […] - 2025-04-02 05:16:52
Commonwealth Equity Services LLC Decreases Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Commonwealth Equity Services LLC trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 14.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,853 shares of the medical research company’s stock after selling 1,932 shares during the quarter. […] - 2025-03-28 07:54:50
Corient Private Wealth LLC Has $1.49 Million Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Corient Private Wealth LLC reduced its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 32.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,082 shares of the medical research company’s stock after selling 3,876 shares during […] - 2025-03-26 09:12:55
Charles River Laboratories International (NYSE:CRL) Cut to Neutral at The Goldman Sachs Group
The Goldman Sachs Group downgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a buy rating to a neutral rating in a report issued on Friday, MarketBeat Ratings reports. They currently have $170.00 price objective on the medical research company’s stock, down from their prior price objective of $190.00. Several other equities […] - 2025-03-24 07:00:43
M&T Bank Corp Buys 245 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
M&T Bank Corp increased its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 12.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,246 shares of the medical research company’s stock after buying an additional 245 shares […] - 2025-03-14 08:08:57
Raymond James Financial Inc. Makes New Investment in Charles River Laboratories International, Inc. (NYSE:CRL)
Raymond James Financial Inc. acquired a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 231,720 shares of the medical research company’s stock, valued at approximately $42,776,000. A number of other large investors have also added to or reduced their stakes in […] - 2025-03-13 08:35:38
Assetmark Inc. Has $1.80 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Assetmark Inc. grew its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5,099.5% during the 4th quarter, Holdings Channel reports. The firm owned 9,775 shares of the medical research company’s stock after purchasing an additional 9,587 shares during the quarter. Assetmark Inc.’s holdings in Charles River Laboratories International were worth $1,804,000 […] - 2025-03-11 08:20:57
Charles Schwab Investment Management Inc. Boosts Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Charles Schwab Investment Management Inc. boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 552,975 shares of the medical research company’s stock after acquiring an additional […] - 2025-03-10 08:44:49
1,382 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Acquired by QRG Capital Management Inc.
QRG Capital Management Inc. bought a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 1,382 shares of the medical research company’s stock, valued at approximately $255,000. Other hedge funds have also added to or reduced their stakes in the […] - 2025-03-07 09:30:55
Charles River Laboratories International, Inc. (NYSE:CRL) Receives $198.36 Consensus Price Target from Brokerages
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average recommendation of “Hold” from the sixteen brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, fourteen have given a hold rating and one has given a buy rating to the company. The […] - 2025-03-07 08:38:58
Charles River Laboratories International (NYSE:CRL) Stock Rating Upgraded by Redburn Atlantic
Charles River Laboratories International (NYSE:CRL – Get Free Report) was upgraded by research analysts at Redburn Atlantic from a “sell” rating to a “neutral” rating in a report issued on Monday, Marketbeat reports. The brokerage presently has a $188.00 target price on the medical research company’s stock. Redburn Atlantic’s target price would suggest a potential […] - 2025-03-05 07:04:54
Insiders Pile Into Holdings of FTXH ETF
A look at the weighted underlying holdings of the First Trust Nasdaq Pharmaceuticals ETF (FTXH) shows an impressive 23.8% of holdings on a weighted basis have experienced insider buying within the past six months. Charles River Laboratories International Inc. (Symbol: CRL), wh - 2025-02-26 14:32:53
Charles River Laboratories International (NYSE:CRL) Shares Up 3.9% on Insider Buying Activity
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report)’s stock price rose 3.9% during trading on Monday after an insider bought additional shares in the company. The stock traded as high as $172.45 and last traded at $169.45. Approximately 274,567 shares were traded during trading, a decline of 73% from the average daily volume […] - 2025-02-25 06:05:00
Charles River Laboratories International (NYSE:CRL) Shares Gap Up After Better-Than-Expected Earnings
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) shares gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $154.39, but opened at $159.28. Charles River Laboratories International shares last traded at $160.76, with a volume of 152,366 shares changing […] - 2025-02-21 06:56:44
Barclays Cuts Charles River Laboratories International (NYSE:CRL) Price Target to $166.00
Charles River Laboratories International (NYSE:CRL – Get Free Report) had its price target cut by equities research analysts at Barclays from $205.00 to $166.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the medical research company’s stock. Barclays‘s price target indicates a potential upside of 0.61% from […] - 2025-02-20 06:58:45
Charles River Laboratories Q4 24 Earnings Conference Call At 8:30 AM ET
(RTTNews) - Charles River Laboratories International Inc. (CRL) will host a conference call at 8:30 AM ET on February 19, 2025, to discuss Q4 24 earnings results. - 2025-02-19 12:31:18
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by New York State Teachers Retirement System
New York State Teachers Retirement System decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 11.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,230 shares of the medical research company’s stock after selling […] - 2025-02-19 10:44:53
Charles River Laboratories International, Inc. (NYSE:CRL) Stock Position Decreased by Louisiana State Employees Retirement System
Louisiana State Employees Retirement System cut its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,800 shares of the medical research company’s stock after selling 100 […] - 2025-02-19 10:10:54
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by V Square Quantitative Management LLC
V Square Quantitative Management LLC raised its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 12.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,084 shares of the medical research company’s stock after buying an additional 121 shares during the quarter. V Square […] - 2025-02-18 09:28:57
Chevy Chase Trust Holdings LLC Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Chevy Chase Trust Holdings LLC decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,834 shares of the medical research company’s stock after selling 849 shares during […] - 2025-02-18 08:44:51
Van ECK Associates Corp Has $8.93 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Van ECK Associates Corp lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,380 shares of the medical research company’s stock after selling 2,893 shares during the quarter. […] - 2025-02-17 08:49:11

CRL institutional holdings

The following institutional investment holdings of CRL have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 117,922 -0.2%USD 16,669,454 2.9%
2025-05-08 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 117,922USD 16,669,454
2025-05-08 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 117,922USD 16,669,454
2025-02-27 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 68,228USD 11,249,433 -1.9%
2025-02-27 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 68,228USD 11,249,433 -1.9%
2025-02-27 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 68,228USD 11,249,433 -1.9%
2025-02-27 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 68,228USD 11,249,433 -1.9%
2025-02-27 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 10,092 -0.2%USD 1,663,969 -2.1%
2025-05-08 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 18,903USD 2,672,128 3.1%
2025-02-27 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 8,869USD 1,462,321 -1.9%
2025-02-27 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 12,805 -0.1%USD 2,111,288 -2.0%
2025-02-27 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 12,805 -0.1%USD 2,111,288 -2.0%
2025-02-27 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 12,805 -0.1%USD 2,111,288 -2.0%
2024-11-18 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 5,730 195.5%USD 1,074,375 212.4%
2024-11-18 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 5,730 195.5%USD 1,074,375 212.4%
2025-02-27 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 4,620USD 761,746 -1.9%
2025-05-08 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 7,580USD 950,130 3.9%
2025-02-27 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 1,024USD 168,837 -1.9%
2025-02-27 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 1,024USD 168,837 -1.9%
2025-02-27 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 4,019USD 662,653 -1.9%
2025-02-27 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 4,019USD 662,653 -1.9%
2025-05-08 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 58,134USD 8,217,822
2025-05-08 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 58,134 -1.4%USD 8,217,822 1.8%
2024-11-12 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 2,748 0.4%USD 559,313 -1.4%
2025-05-08 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 24,908 0.2%USD 3,520,995 3.3%
2025-05-08 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 24,908 0.2%USD 3,520,995 3.3%
2025-02-27 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 1,806USD 297,773 -1.9%
2025-02-27 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 1,166USD 192,250 -1.9%
2025-05-08 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 66,589USD 9,413,021 3.1%
2025-02-27 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 994USD 163,891 -1.9%
2024-11-12 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 1,272USD 274,676
2025-05-08 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 1,124USD 119,380 3.5%
2025-05-08 IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc)) 714USD 100,931 3.1%
2025-02-27 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 267USD 34,861 -1.3%
2025-02-27 IE00BP3QZD73 (iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc)) 1,706USD 281,285 -1.9%
2025-02-27 IE00BD1F4K20 (iShares MSCI USA Mid-Cap Equal Weight UCITS ETF USD (Acc)) 4,790USD 789,775 -1.9%
2025-05-08 IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF) 335 8.4%USD 47,356 11.2%
2025-02-27 IE000YNE6S57 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Dist)) 9USD 1,484 -1.9%
2025-02-27 IE0001YGXFO5 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Acc)) 9USD 1,484 -1.9%
2025-02-27 IE000YG82CF0 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Dist)) 7USD 1,154 -1.9%
2025-02-27 IE000MGAVJV3 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Acc)) 7USD 1,154 -1.9%
2025-02-27 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 8,869USD 1,462,321 -1.9%
2024-11-08 IE000X08RX14 (iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc)) 958USD 206,344 2.4%
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 33,336USD 4,712,377
2024-12-10 IE00B3VWMM18 (iShares MSCI EMU Small Cap UCITS) 96,424EUR 1,860,983 1.2%
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 24,530USD 3,467,561 3.1%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 587USD 82,978 3.1%
Total =1,151,034 USD 160,211,968
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.